Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2013; 19(13): 2097-2103
Published online Apr 7, 2013. doi: 10.3748/wjg.v19.i13.2097
Published online Apr 7, 2013. doi: 10.3748/wjg.v19.i13.2097
Figure 1 Patients with complete response.
A, B: Abdominal computed tomography (CT) in patients with gastric cancer with multiple synchronous liver metastases (GCLM) after preoperative chemotherapy; C, D: Abdominal CT in patients with GCLM after neoadjuvant chemotherapy.
Figure 2 Patients with partial response.
A: Abdominal computed tomography (CT) in gastric cancer with multiple synchronous liver metastases (GCLM) patient treated with preoperative chemotherapy (June 3, 2011); B: Abdominal CT in patient with GCLM after neoadjuvant chemotherapy (August 29, 2011); C: Abdominal CT in patient with GCLM after neoadjuvant chemotherapy (November 8, 2011); D: Abdominal CT in patient with GCLM after neoadjuvant chemotherapy (February 2, 2012).
Figure 3 Overall survival of patients with hepatic metastases from gastric cancer.
- Citation: Chen L, Song MQ, Lin HZ, Hao LH, Jiang XJ, Li ZY, Chen YX. Chemotherapy and resection for gastric cancer with synchronous liver metastases. World J Gastroenterol 2013; 19(13): 2097-2103
- URL: https://www.wjgnet.com/1007-9327/full/v19/i13/2097.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i13.2097